Leveraging the advances in HIV for COVID-19.
Publication
, Journal Article
McMahon, JH; Hoy, JF; Kamarulzaman, A; Bekker, L-G; Beyrer, C; Lewin, SR
Published in: Lancet
October 3, 2020
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Lancet
DOI
EISSN
1474-547X
Publication Date
October 3, 2020
Volume
396
Issue
10256
Start / End Page
943 / 944
Location
England
Related Subject Headings
- Vulnerable Populations
- SARS-CoV-2
- Risk Factors
- Pneumonia, Viral
- Pandemics
- Humans
- HIV Infections
- Global Health
- General & Internal Medicine
- Coronavirus Infections
Citation
APA
Chicago
ICMJE
MLA
NLM
McMahon, J. H., Hoy, J. F., Kamarulzaman, A., Bekker, L.-G., Beyrer, C., & Lewin, S. R. (2020). Leveraging the advances in HIV for COVID-19. Lancet, 396(10256), 943–944. https://doi.org/10.1016/S0140-6736(20)32012-2
McMahon, James H., Jennifer F. Hoy, Adeeba Kamarulzaman, Linda-Gail Bekker, Chris Beyrer, and Sharon R. Lewin. “Leveraging the advances in HIV for COVID-19.” Lancet 396, no. 10256 (October 3, 2020): 943–44. https://doi.org/10.1016/S0140-6736(20)32012-2.
McMahon JH, Hoy JF, Kamarulzaman A, Bekker L-G, Beyrer C, Lewin SR. Leveraging the advances in HIV for COVID-19. Lancet. 2020 Oct 3;396(10256):943–4.
McMahon, James H., et al. “Leveraging the advances in HIV for COVID-19.” Lancet, vol. 396, no. 10256, Oct. 2020, pp. 943–44. Pubmed, doi:10.1016/S0140-6736(20)32012-2.
McMahon JH, Hoy JF, Kamarulzaman A, Bekker L-G, Beyrer C, Lewin SR. Leveraging the advances in HIV for COVID-19. Lancet. 2020 Oct 3;396(10256):943–944.
Published In
Lancet
DOI
EISSN
1474-547X
Publication Date
October 3, 2020
Volume
396
Issue
10256
Start / End Page
943 / 944
Location
England
Related Subject Headings
- Vulnerable Populations
- SARS-CoV-2
- Risk Factors
- Pneumonia, Viral
- Pandemics
- Humans
- HIV Infections
- Global Health
- General & Internal Medicine
- Coronavirus Infections